Ligand-based pharmacophore modeling; Atom-based 3D-QSAR analysis and molecular docking studies of phosphoinositide-dependent kinase-1 inhibitors

Indian Journal of Pharmaceutical Sciences

Volumn 74, Issue 2, 2012, Pages 141-151

  Kirubakaran, P ^a   Muthusamy, K ^a   Singh, K H D ^a   Nagamani, S ^a  

^a ALAGAPPA UNIVERSITY   (India)

Author keywords

3D QSAR; External validation; molecular docking and prime MM GBSA; PDK1; PHASE

Indexed keywords

HYDROGEN; LIGAND; PHOSPHOINOSITIDE DEPENDENT KINASE 1 INHIBITOR; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; EXTERNAL VALIDITY; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR DOCKING; PHARMACOPHORE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SIGNAL TRANSDUCTION;

EID: 84871940596     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.103846     Document Type: Article

References (24)

1. Lawlor MA, Mora A, Ashby PR, Williams MR, Murray-Tait V, Malone L, et al. Essential role of PDK1 in regulating cell size and development in mice. EMBO J 2002;14:3728-38.
2. Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, et al. Phosphorylation and Activation of p70s6k by PDK1. Science 1998;5351:707-10.
3. Mora A, Komander D, van Aalten D, Alessi D. PDK1, the master regulator of AGC kinase signal transduction. Sem Cell Dev Biol 2004;2:161-70.
4. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, et al. Synthesis and function of 3-Phosphorylated Inositol lipids. Annu Rev Biochem 2001;1:535-602.
5. Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: Its functions and alterations in human cancer. Apoptosis 2004;6:667-76.
6. Hanada M, Feng J, Hemmings BA. Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim Biophys Acta 2004;1-2:3-16.
7. Zhang Q, Thomas SM, Lui VW, Xi S, Siegfried JM, Fan H, et al. Phosphorylation of TNF-α converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. PNAS 2006;18:6901-6.
8. Baryawno N, Sveinbjornsson B, Eksborg S, Chen CS, Kogner P, Johnsen JI. Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/beta-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth. Cancer Res 2010;1:266-76.
9. Zeng X, Xu H, Glazer RI. Transformation of Mammary Epithelial Cells by 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) Is Associated with the Induction of Protein Kinase C Alpha. Cancer Res 2002;12:3538-43.
10. Flynn P, Wong M, Zavar M, Dean NM, Stokoe D. Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival. Curr Biol 2000;22:1439-42.
11. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. Nucleic Acids Res 2000;1:235-42.
12. Peifer C, Alessi DR. Small-Molecule Inhibitors of PDK1. Chem Med Chem 2008;12:1810-38.
13. Dixon S, Smondyrev A, Knoll E, Rao S, Shaw D, Friesner R. PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des 2006;10:647-71.
14. Evans DA, Doman TN, Thorner DA, Bodkin MJ. 3D QSAR Methods: Phase and Catalyst Compared. J Chem Inf Model 2007;3:1248-57.
15. Bagchi MC, Maiti BC. On application of atom pairs in drug design. J Mol Struct 2003;1-3:31-7.
16. Nandi S, Vracko M, Bagchi MC. Anticancer Activity of Selected Phenolic Compounds: QSAR Studies Using Ridge Regression and Neural Networks. Chem Biol Drug Des 2007;5:424-36.
17. Golbraikh A, Tropsha A. Beware of q2! J Mol Graph Model 2002;4:269-76.
18. Kar S, Roy K. Development and validation of a robust QSAR model for prediction of carcinogenicity of drugs. Indian J Biochem Biophys 2011;48:111-22.
19. UMETRICS SIMCA-P 12.0, info@umetrics.com: www.umetrics.com, Umea, Sweden, 2002.
20. Mitra I, Saha A, Roy K. Development of multiple QSAR models for consensus predictions and unified mechanistic interpretations of the free-radical scavenging activities of chromone derivatives. J Mol Model 2012;18:1819-40.
21. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, et al. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J Med Chem 2004;7:1739-49.
22. Wang S, Folkes A, Chuckowree I, Cockcroft X, Sohal S, Miller W, et al. Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance. J Med Chem 2004;6:1329-38.
23. Wang S, Wan NC, Harrison J, Miller W, Chuckowree I, Sohal S, et al. Design and Synthesis of New Templates Derived from Pyrrolopyrimidine as Selective Multidrug-Resistance-Associated Protein Inhibitors in Multidrug Resistance. J Med Chem 2004;6:1339-50.
24. Nagamani S, Karthikeyan M, Kirubakaran P, Singh KD, Gopinath K. Theoretical studies on benzimidazole derivatives as E. coli biotin carboxylase inhibitors. Med Chem Res 2012;21:2169-80.